# CTXR (Citius Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Citius Pharmaceuticals, Inc. reported $142.3M in total assets and a net loss of $46.27M through September 30, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CTXR
- Markdown: https://convexityos.com/fundamentals/CTXR.md
- SEC CIK: 0001506251
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001506251&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Sep 30, 2025 |
| Operating Income | FY 2025 | -$61.38M | Operating profit |
| Net Income | FY 2025 | -$46.27M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.77 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $17.01M | Total debt: $300.8M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $90K | $90K | $90K | $90K | $75K | $50K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $75K | $50K | $45K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | -- |
| Research & Development | $9.16M | $11.91M | $14.82M | $17.66M | $12.24M | $8.81M | $8.60M | $6.56M | $2.94M | $2.93M |
| Total Operating Expenses | $38.53M | $42.00M | $36.73M | $33.32M | $23.53M | $17.71M | $15.60M | $13.79M | $9.99M | $7.45M |
| **Operating Income** | -$38.53M | -$42.00M | -$36.73M | -$33.32M | -$23.53M | -$17.71M | -$15.60M | -$13.79M | -$9.99M | -$7.45M |
| **EBITDA** | -- | -$41.99M | -$36.73M | -$33.31M | -$23.53M | -$17.71M | -$15.60M | -$13.79M | -$9.98M | -$7.45M |
| Interest Income | $110K | $758K | $1.18M | $251K | $262K | $68K | $53K | -- | -- | $806 |
| Interest Expense | $268K | -- | -- | -- | $11K | $16K | $16K | $16K | $851K | $9.0K |
| Income Before Tax | -$38.68M | -$38.85M | -$31.97M | -$33.06M | -$23.05M | -$17.55M | -$15.56M | $12.54M | $10.38M | -$8.30M |
| Income Tax Expense | $1.06M | $576K | $576K | $576K | $1.2K | $741 | -- | -- | -- | -- |
| **Net Income** | -$37.43M | -$40.19M | -$32.54M | -$33.64M | -$23.05M | -$17.55M | -$15.56M | -$12.54M | -$10.38M | -$8.30M |
| Basic EPS | -$3.38 | -$5.97 | -$5.57 | -$0.23 | -$0.23 | -$0.45 | -$0.77 | -$1.17 | -$1.89 | -$2.29 |
| **Diluted EPS** | -$3.38 | -$5.97 | -$5.57 | -$0.23 | -$0.23 | -$0.45 | -$0.77 | -$1.17 | -$1.89 | -$2.29 |
| Basic Shares Outstanding | 11.1M | 6.7M | 6.1M | 146.1M | 108.6M | 39.2M | 20.2M | 10.7M | 5.5M | 3.6M |
| Diluted Shares Outstanding | 11.1M | 6.7M | 6.1M | 146.1M | 108.6M | 39.2M | 20.2M | 10.7M | 5.5M | 3.6M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.49M | $1.67M | $3.94M | -- | -- | -- | -- | -- |
| Cost of Revenue | $492K | $329K | $789K | -- | -- | -- | -- | -- |
| **Gross Profit** | $1.00M | $1.34M | $3.15M | -- | -- | -- | -- | -- |
| Research & Development | $1.05M | $1.63M | $1.60M | $1.64M | $1.62M | $3.77M | $2.13M | $2.91M |
| Total Operating Expenses | $12.73M | $33.53M | $12.17M | $8.44M | $8.79M | $11.26M | $10.04M | $11.05M |
| **Operating Income** | -$11.73M | -$32.19M | -$9.02M | -$8.44M | -$8.79M | -$11.26M | -$10.04M | -$11.05M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$11.05M |
| Interest Income | $117K | $54K | $45K | $53K | $21K | $13K | $23K | $117K |
| Interest Expense | $198K | $33K | $156K | -- | $172K | -- | -- | -- |
| Income Before Tax | -$12.03M | -$28.34M | -$9.13M | -$8.48M | -$8.94M | -$11.25M | -$10.02M | -$10.93M |
| Income Tax Expense | -$107K | -$231K | $264K | $264K | $264K | $264K | $264K | $144K |
| **Net Income** | -$8.86M | -$21.23M | -$8.22M | -$7.96M | -$8.79M | -$11.51M | -$10.28M | -$11.52M |
| Basic EPS | -$0.34 | -$0.95 | -$0.38 | -- | -$0.80 | -$1.27 | -$1.30 | -- |
| **Diluted EPS** | -$0.34 | -$0.95 | -$0.38 | -- | -$0.80 | -$1.27 | -$1.30 | -- |
| Basic Shares Outstanding | 26.2M | 22.4M | 21.5M | -- | 11.0M | 8.6M | 7.5M | -- |
| Diluted Shares Outstanding | 26.2M | 22.4M | 21.5M | -- | 11.0M | 8.6M | 7.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.20M | $294K |
| **Cash & Short-Term Investments** | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.20M | $294K |
| Inventory | $22.29M | $8.27M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $19.40M |
| **Total Current Assets** | $27.93M | $14.22M | $34.37M | $44.56M | $72.81M | $13.98M | $7.94M | $10.06M | $3.42M | $893K |
| Property, Plant & Equipment, Net | -- | -- | $1.4K | $4.1K | $7.0K | $1.6K | $590 | $1.5K | $3.2K | $3.7K |
| Goodwill | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $1.59M | $1.59M | $1.59M |
| Other Non-Current Assets | $102.2M | $102.2M | $68.78M | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $103.0M | $102.4M | $69.24M | $69.44M | $69.61M | $29.79M | $28.80M | $20.99M | $20.99M | $21.06M |
| **Total Assets** | $130.9M | $116.7M | $103.6M | $114.0M | $142.4M | $43.77M | $36.75M | $31.05M | $24.42M | $21.95M |
| Accounts Payable | $13.69M | $4.93M | $2.93M | $1.17M | $1.28M | $1.86M | $2.71M | $1.57M | $602K | $909K |
| Short-Term Debt | $300.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $44.91M | $35.81M | $5.78M | $4.53M | $3.98M | $4.10M | $4.61M | $3.18M | $2.47M | $5.18M |
| **Total Non-Current Liabilities** | $8.50M | $6.74M | $6.40M | $6.04M | $5.66M | $6.01M | $4.99M | -$2.77M | $0 | $0 |
| **Total Liabilities** | $53.41M | $42.55M | $12.18M | $10.57M | $9.65M | $10.10M | $9.59M | $411K | $2.47M | $5.18M |
| **Total Debt (incl. Leases)** | $300.8M | $263K | $481K | $678K | $855K | $1.01M | $1.14M | -- | -- | -- |
| Common Stock | $18K | $7.2K | $6.4K | $146K | $146K | $56K | $29K | $16K | $8.3K | $4.9K |
| Retained Earnings | -$238.8M | -$201.4M | -$162.2M | -$129.7M | -$96.05M | -$70.59M | -$53.05M | -$40.26M | -$27.72M | -$17.34M |
| **Total Stockholders' Equity** | $67.55M | $70.08M | $90.83M | $102.8M | $132.2M | $33.67M | $27.15M | $30.64M | $21.95M | $16.77M |
| Total Equity | $77.53M | $74.10M | $91.43M | $103.4M | $132.8M | $33.67M | $27.15M | $30.64M | $21.95M | $16.77M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.01M | $4.59M | $7.72M | $4.25M | $6.09M | $26K | $1.10M | $3.25M |
| **Cash & Short-Term Investments** | $17.01M | $4.59M | $7.72M | $4.25M | $6.09M | $26K | $1.10M | $3.25M |
| Accounts Receivable, Net | $686K | $1.08M | $4.05M | -- | -- | -- | -- | -- |
| Inventory | $22.63M | $22.66M | $22.64M | $22.29M | $17.21M | $15.34M | $14.38M | $8.27M |
| **Total Current Assets** | $43.33M | $31.69M | $37.95M | $27.93M | $24.61M | $18.37M | $18.33M | $14.22M |
| Goodwill | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M |
| Other Non-Current Assets | $98.17M | $100.1M | $101.6M | $102.2M | $102.2M | $102.2M | $102.2M | $102.2M |
| **Total Non-Current Assets** | $98.92M | $100.9M | $102.4M | $103.0M | $103.1M | $103.1M | $102.4M | $102.4M |
| **Total Assets** | $142.3M | $132.5M | $140.4M | $130.9M | $127.7M | $121.5M | $120.7M | $116.7M |
| Accounts Payable | $8.04M | $9.45M | $11.02M | $13.69M | $10.09M | $9.37M | $7.36M | $4.93M |
| Short-Term Debt | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | -- |
| **Total Current Liabilities** | $51.65M | $55.02M | $38.21M | $44.91M | $51.84M | $49.88M | $44.81M | $35.81M |
| **Total Non-Current Liabilities** | $14.70M | $8.44M | $8.72M | $8.50M | $8.27M | $8.03M | $6.98M | $6.74M |
| **Total Liabilities** | $66.35M | $63.46M | $46.92M | $53.41M | $60.12M | $57.91M | $51.78M | $42.55M |
| **Total Debt (incl. Leases)** | $300.8M | $300.8M | $300.8M | $300.8M | $300.9M | $300.9M | $300.2M | $263K |
| Common Stock | $27K | $22K | $22K | $18K | $14K | $8.8K | $7.7K | $7.2K |
| Retained Earnings | -$277.1M | -$268.3M | -$247.0M | -$238.8M | -$230.8M | -$222.1M | -$211.1M | -$201.4M |
| **Total Stockholders' Equity** | $66.61M | $61.54M | $79.96M | $67.55M | $65.06M | $60.66M | $65.41M | $70.08M |
| Total Equity | $75.91M | $69.08M | $93.47M | $77.53M | $67.56M | $63.58M | $68.92M | $74.10M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$39.74M | -$39.43M | -$32.54M | -$33.64M | -$23.05M | -$17.55M | -$15.56M | -$12.54M | -$10.38M | -$8.30M |
| Depreciation & Amortization | -- | $1.4K | $2.7K | $2.9K | $1.5K | $844 | $893 | $1.8K | $2.6K | $1.3K |
| Stock-Based Compensation | $10.84M | $11.84M | $6.62M | $3.91M | $1.45M | $803K | $716K | $780K | $987K | $732K |
| Change in Inventory | -$12.65M | -$2.13M | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | $8.77M | $2.00M | $1.76M | -$112K | -$579K | -$857K | $1.14M | $971K | -$307K | $105K |
| **Operating Cash Flow** | -$26.55M | -$28.20M | -$29.06M | -$28.36M | -$24.25M | -$16.93M | -$12.44M | -$11.32M | -$7.97M | -$5.90M |
| Capital Expenditure | -- | -- | -- | -- | -$6.9K | -$1.8K | -- | -- | -$2.1K | -- |
| **Free Cash Flow** | -- | -- | -- | -- | -$24.26M | -$16.93M | -- | -- | -$7.97M | -- |
| **Investing Cash Flow** | -$5.75M | -$5.00M | -- | -- | -$40.01M | -$1.8K | -- | -- | -$2.1K | $256K |
| Common Stock Issued | $32.30M | $13.80M | -- | -- | $500 | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $33.30M | $9.97M | $13.83M | -- | $120.5M | $22.90M | $11.15M | $17.30M | $10.88M | $5.26M |
| **Net Change in Cash** | $1.00M | -$23.23M | -$15.23M | -$28.36M | $56.21M | $5.97M | -$1.29M | $5.98M | $2.91M | -$382K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.92M | -$28.11M | -$9.39M | -$8.74M | -$9.20M | -$11.51M | -$10.28M | -$11.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 |
| Stock-Based Compensation | $3.81M | $3.79M | $4.28M | $2.89M | $2.72M | $2.70M | $2.52M | $2.64M |
| Change in Inventory | $34K | -$20K | -$353K | -$3.71M | -$1.87M | -$958K | -$6.11M | -- |
| Change in Payables | -$1.42M | -$1.57M | -$2.67M | $3.60M | $726K | $2.00M | $2.44M | $3.26M |
| **Operating Cash Flow** | -$8.68M | -$1.30M | -$13.01M | -$11.88M | -$5.41M | -$4.54M | -$4.73M | -$5.91M |
| **Investing Cash Flow** | -$2.00M | -$600K | -$4.40M | -- | -- | -- | -- | -- |
| Common Stock Issued | $4.45M | -$63K | $20.88M | $15.79M | $10.47M | $3.47M | $2.57M | -- |
| **Financing Cash Flow** | $23.09M | -$1.23M | $20.88M | $15.79M | $11.47M | $3.47M | $2.57M | -- |
| **Net Change in Cash** | $12.42M | -$3.13M | $3.47M | -$1.84M | $6.06M | -$1.07M | -$2.15M | -$14.66M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 0.0% | 0.0% | -- |
| **Operating Margin** | -- | -- | -- | -37017.8% | -26146.5% | -19678.5% | -17331.5% | -18385.5% | -19972.6% | -- |
| **Net Profit Margin** | -- | -- | -- | -37378.5% | -25616.0% | -19497.9% | -17291.3% | -16715.5% | -20769.9% | -- |
| Return on Equity (ROE) | -55.4% | -57.3% | -35.8% | -32.7% | -17.4% | -52.1% | -57.3% | -40.9% | -47.3% | -49.5% |
| Return on Assets (ROA) | -28.6% | -34.4% | -31.4% | -29.5% | -16.2% | -40.1% | -42.4% | -40.4% | -42.5% | -37.8% |
| Current Ratio | 0.62x | 0.40x | 5.95x | 9.84x | 18.28x | 3.41x | 1.72x | 3.16x | 1.39x | 0.17x |
| Quick Ratio | 0.13x | 0.17x | 4.58x | 9.21x | 17.60x | 3.38x | 1.71x | 2.88x | 1.30x | 0.06x |
| Debt to Equity | 4.45x | 0.00x | 0.01x | 0.01x | 0.01x | 0.03x | 0.04x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | 0.0% | 0.0% | 0.0% | +20.0% | +50.0% | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -93.2% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -69.5% | -75.1% | -45.6% | -57.1% | -64.7% | -72.3% | -62.6% | -30.5% |
| Return on Assets (ROA) | -32.5% | -34.9% | -26.0% | -29.4% | -33.0% | -36.1% | -33.9% | -18.3% |
| Current Ratio | 0.84x | 0.58x | 0.99x | 0.62x | 0.47x | 0.37x | 0.41x | 0.40x |
| Quick Ratio | 0.40x | 0.16x | 0.40x | 0.13x | 0.14x | 0.06x | 0.09x | 0.17x |
| Debt to Equity | 4.52x | 4.89x | 3.76x | 4.45x | 4.62x | 4.96x | 4.59x | 0.00x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -211.4% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
